TAP1 and bladder transitional cell carcinoma: In our study, patients with BLCA, BRCA, and SKCM and high TAP1 expression all exhibited better prognosis, consistent with the cohort analysis; h Especially, we also demonstrated that BLCA and SKCM cancer patients with higher TAP1 expression showed more sensitivity of ICI therapy in our study.